The FDA recently rejected MDMA as a treatment for post-traumatic stress disorder (PTSD). This decision surprised many, given the promising results from clinical trials and support from some psychiatric experts. MDMA, the active ingredient in ecstasy, has been studied along with other psychedelics like psilocybin and ketamine for mental health benefits. However, FDA experts found […]